We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DHER:XETRDelivery Hero SE Analysis

Data as of 2026-03-11 - not real-time

€17.49

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Delivery Hero SE is trading at €17.49, far below its DCF‑derived fair value of roughly €116, indicating a substantial valuation gap. Technical indicators are bearish: the price sits under the 20‑day (≈19.33), 50‑day (≈22.30) and 200‑day (≈22.83) moving averages, RSI is at 36 and MACD shows a bearish divergence. Recent news amplified pressure as Talabat Holding Plc cut its 2026 outlook, triggering an 8% share‑price drop and highlighting margin‑compression concerns. Fundamentally, revenue grew 19% YoY to €13.4 bn, yet profitability remains weak with a negative profit margin and a trailing EPS of –€1.86. The company carries a high debt load (≈€4.6 bn) and a debt‑to‑equity ratio near 200%, but cash generation is positive, delivering €1.2 bn in free cash flow. Volatility is elevated (≈70% 30‑day) while beta is modest (≈0.47), suggesting price swings are driven more by company‑specific factors than market movements. The “Extreme Greed” sentiment index (≈77) signals strong investor appetite, yet the bearish technical backdrop tempers short‑term optimism. With a projected upside of over 60% relative to current levels, the stock presents a classic value‑play if the company can translate revenue growth into sustainable earnings. However, the high geographic exposure across 70 markets and the absence of a dividend add layers of risk. In summary, the stock is deeply undervalued on a discounted‑cash‑flow basis, but short‑term price action is constrained by recent margin concerns and technical weakness.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below all major moving averages
  • Recent 8% drop after Talabat margin outlook cut
  • Bearish MACD and RSI indicating continued downside pressure

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value suggests >60% upside
  • Strong revenue growth (19% YoY) and positive free cash flow
  • Improving forward EPS expectations

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Large addressable market across 70 countries
  • Potential to improve margins as scale and advertising revenue rise
  • Undervalued relative to intrinsic valuation despite high debt

Key Metrics & Analysis

Financial Health

Revenue Growth19.20%
Profit Margin-4.18%
P/E Ratio24.7
ROE-28.92%
ROA0.80%
Debt/Equity198.40
P/B Ratio2.4
Op. Cash Flow€930.5M
Free Cash Flow€1.2B

Technical Analysis

TrendBearish
RSI36.0
Support€16.72
Resistance€22.80
MA 20€19.33
MA 50€22.30
MA 200€22.83
MACDBearish
VolumeIncreasing
Fear & Greed Index76.98

Valuation

Fair Value€116.44
Target Price€28.61
Upside/Downside63.58%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.47
Volatility69.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.